Shoulder arthroplasty in patients with juvenile idiopathic arthritis: long-term outcomes

被引:4
|
作者
Marigi, Erick M. [1 ]
Lee, Dustin [1 ]
Marigi, Ian [1 ]
Werthel, Jean-David [2 ]
Barlow, Jonathan D. [1 ]
Sperling, John W. [1 ]
Sanchez-Sotelo, Joaquin [1 ]
Schoch, Bradley S. [3 ]
机构
[1] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA
[2] Hop Ambroise Pare, Dept Orthoped Surg, Boulogne Billancourt, France
[3] Mayo Clin, Dept Orthoped Surg, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
关键词
Juvenile idiopathic arthritis; hemiarthroplasty; anatomic total shoulder arthroplasty; reverse shoulder arthroplasty; RHEUMATOID-ARTHRITIS; RADIOGRAPHIC EVALUATION; HEMIARTHROPLASTY; REPLACEMENT;
D O I
10.1016/j.jse.2021.06.014
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatologic disease that occurs in the pediatric population. Often, JIA continues throughout life, leading to progressive polyarticular arthritis and significant joint destruction and disability, oftentimes requiring replacement surgery. This study aimed to determine the outcomes of primary shoulder arthroplasty (SA) in patients with JIA. Methods: Over a 42-year time period (1977-2019), 67 primary SA (20 hemiarthroplasty [HA], 38 anatomic total shoulder arthroplasty [TSA], and 9 reverse shoulder arthroplasty [RSA]) with a prior diagnosis of HA formally established in a multidisciplinary rheumatologic clinic met inclusion criteria. Further assessment was performed with inclusion of the visual analog scale pain score, active shoulder range of motion (ROM), imaging studies, complications, and implant survivorship free from reoperation and revision. Results: SA led to substantial improvements in pain and ROM across the entire cohort at an average follow-up period of 12.2 years (range, 2-34 years). TSA was associated with the lowest pain scores (0.8; P - .02) and the highest American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form scores (77.4; P- .04) at the most recent follow-up when compared to HA and RSA. There were 14 (21%) complications across the cohort with rotator cuff failure (n = 4; 5.9%) as the most common complication followed by infection (n = 3; 4.5%). Revision surgery was performed in 5 shoulders (7.5%), with 5-year implant survival rates of 95.1% at 5 years, 93% at 10 years, 89.4% at 20 years, and 79.5% at 30 years. At 30 years, TSA was associated with better survival (90.1%) than HA (71.8%). Conclusions: Primary shoulder arthroplasty in the form of HA, TSA, and RSA offers a reliable surgical option for JIA patients with respect to pain reduction and ROM improvements. Unique challenges still exist in this cohort, in particular younger patients with an elevated propensity for glenoid bone erosion and a complication rate of 20.9%. As such, HA may not be ideal in this patient population. However, despite rotator cuff and glenoid concerns, TSA seems to be associated with better pain relief and patient-reported outcomes with the most durability in the long term when compared to HA. (C) 2021 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights reserved.
引用
收藏
页码:2703 / 2710
页数:8
相关论文
共 50 条
  • [41] Long-term followup of temporomandibular joint involvement in juvenile idiopathic arthritis
    Twilt, Marinka
    Schulten, Alcuin J. M.
    Verschure, Femke
    Wisse, Lauke
    Prahl-Andersen, Birte
    Van Suijlekom-Smit, Lisette W. A.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (04): : 546 - 552
  • [42] Resurfacing hemiarthroplasty of the shoulder for patients with juvenile idiopathic arthritis
    Ibrahim, Edward F.
    Rashid, Abbas
    Thomas, Michael
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2018, 27 (08) : 1468 - 1474
  • [43] Disease activity, treatment and long-term prognosis of adult juvenile idiopathic arthritis patients compared with rheumatoid arthritis patients
    Matsumoto, Takumi
    Matsui, Toshihiro
    Hirano, Fumio
    Tohma, Shigeto
    Mori, Masaaki
    MODERN RHEUMATOLOGY, 2020, 30 (01) : 78 - 84
  • [44] Predictors of long-term functional outcomes of juvenile idiopathic arthritis-enthesitis-related arthritis: a single centre experience
    Ravichandran, Naveen
    Guleria, Shivika
    Mohindra, Namita
    Aggarwal, Amita
    RHEUMATOLOGY, 2023, 62 (09) : 3110 - 3116
  • [45] Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
    Yueh Su
    Yao-Hsu Yang
    Bor-Luen Chiang
    Clinical Rheumatology, 2017, 36 : 1997 - 2004
  • [46] Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis The Importance of Definition
    Shoop-Worrall, Stephanie J. W.
    Verstappen, Suzanne M. M.
    McDonagh, Janet E.
    Baildam, Eileen
    Chieng, Alice
    Davidson, Joyce
    Foster, Helen
    Ioannou, Yiannis
    McErlane, Flora
    Wedderburn, Lucy R.
    Thomson, W.
    Hyrich, Kimme L.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (09) : 1519 - 1529
  • [47] Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes
    Su, Yueh
    Yang, Yao-Hsu
    Chiang, Bor-Luen
    CLINICAL RHEUMATOLOGY, 2017, 36 (09) : 1997 - 2004
  • [48] Long-Term Follow-Up of Orthognathic Surgery in 19 Patients with Juvenile Idiopathic Arthritis
    Krarup, Henrik
    Pedersen, Thomas Klit
    Frid, Paula
    Norholt, Sven Erik
    JOMR-JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, 2023, 14 (04):
  • [49] Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)
    Klotsche, Jens
    Niewerth, Martina
    Haas, Johannes-Peter
    Huppertz, Hans-Iko
    Zink, Angela
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 855 - 861
  • [50] Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis
    Breitbach, Marc
    Tappeiner, Christoph
    Boehm, Michael R. R.
    Zurek-Imhoff, Beatrix
    Heinz, Carsten
    Thanos, Solon
    Ganser, Gerd
    Heiligenhaus, Arnd
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (01) : 171 - 177